» Articles » PMID: 22427612

Mortality Prediction by Surrogates of Body Composition: an Examination of the Obesity Paradox in Hemodialysis Patients Using Composite Ranking Score Analysis

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 2012 Mar 20
PMID 22427612
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

In hemodialysis patients, lower body mass index and weight loss have been associated with higher mortality rates, a phenomenon sometimes called the obesity paradox. This apparent paradox might be explained by loss of muscle mass. The authors thus examined the relation to mortality of changes in dry weight and changes in serum creatinine levels (a muscle-mass surrogate) in a cohort of 121,762 hemodialysis patients who were followed for up to 5 years (2001-2006). In addition to conventional regression analyses, the authors conducted a ranking analysis of joint effects in which the sums and differences of the percentiles of change for the 2 measures in each patient were used as the regressors. Concordant with previous body mass index observations, lower body mass, lower muscle mass, weight loss, and serum creatinine decline were associated with higher death rates. Among patients with a discordant change, persons whose weight declined but whose serum creatinine levels increased had lower death rates than did those whose weight increased but whose serum creatinine level declined. A decline in serum creatinine appeared to be a stronger predictor of mortality than did weight loss. Assuming residual selection bias and confounding were not large, the present results suggest that a considerable proportion of the obesity paradox in dialysis patients might be explained by the amount of decline in muscle mass.

Citing Articles

Harnessing Artificial Intelligence in Obesity Research and Management: A Comprehensive Review.

Azmi S, Kunnathodi F, Alotaibi H, Alhazzani W, Mustafa M, Ahmad I Diagnostics (Basel). 2025; 15(3).

PMID: 39941325 PMC: 11816645. DOI: 10.3390/diagnostics15030396.


Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in Mice.

Heitman K, Bollenbecker S, Bradley J, Czaya B, Fajol A, Thomas S Int J Mol Sci. 2024; 25(17).

PMID: 39273260 PMC: 11395169. DOI: 10.3390/ijms25179308.


Identification of Time-Series Pattern Marker in Its Application to Mortality Analysis of Pneumonia Patients in Intensive Care Unit.

Lee S, Kim S, Koh G, Ahn H J Pers Med. 2024; 14(8).

PMID: 39202004 PMC: 11355743. DOI: 10.3390/jpm14080812.


Association Between Low Kidney Function and Excess Weight Concerning Unfavourable Periodontal Health among Community-dwelling Older Japanese Women.

Yoshihara A, Iwasaki M, Suwama K, Nakamura K Oral Health Prev Dent. 2024; 22:293-300.

PMID: 39042036 PMC: 11619855. DOI: 10.3290/j.ohpd.b5573943.


Skeletal Muscle Injury in Chronic Kidney Disease-From Histologic Changes to Molecular Mechanisms and to Novel Therapies.

Heitman K, Alexander M, Faul C Int J Mol Sci. 2024; 25(10).

PMID: 38791164 PMC: 11121428. DOI: 10.3390/ijms25105117.


References
1.
Kovesdy C, Kalantar-Zadeh K . Why is protein-energy wasting associated with mortality in chronic kidney disease?. Semin Nephrol. 2009; 29(1):3-14. PMC: 5500837. DOI: 10.1016/j.semnephrol.2008.10.002. View

2.
Bross R, Chandramohan G, Kovesdy C, Oreopoulos A, Noori N, Golden S . Comparing body composition assessment tests in long-term hemodialysis patients. Am J Kidney Dis. 2010; 55(5):885-96. PMC: 3175362. DOI: 10.1053/j.ajkd.2009.12.031. View

3.
Noori N, Kopple J, Kovesdy C, Feroze U, Sim J, Murali S . Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2010; 5(12):2258-68. PMC: 2994088. DOI: 10.2215/CJN.02080310. View

4.
Kopple J . The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure. Am J Clin Nutr. 2005; 81(6):1257-66. DOI: 10.1093/ajcn/81.6.1257. View

5.
Elsayed E, Tighiouart H, Weiner D, Griffith J, Salem D, Levey A . Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis. 2008; 52(1):49-57. PMC: 2693892. DOI: 10.1053/j.ajkd.2008.04.002. View